Skip Navigation

卫生: 禽流感

新闻

  • 打印
  • 发表评论
  • | 共享

India's trees are potential Tamiflu source

T. V. Padma

2009年4月1日 | EN

Araucaria excelsa

Flickr/ting0308

[NEW DELHI] Trees growing in a biodiversity hotspot in western India could yield a key substance needed to make the bird flu drug Tamiflu.

A team of scientists in Bangalore reported in Current Science last week (25 March) that they have identified several tree species that contain shikimic acid, a crucial component in the production of Tamiflu, the only drug used against bird flu caused by the H5N1 virus.

The fruits of the Chinese star anise tree, Illicium verum, contain 2–7 per cent shikimic acid and are an important source of the chemical. But the tree is difficult to grow, forms its first batch of fruits only in its sixth year and is unlikely to meet the global market demand, the scientists say.

Plants meet two-thirds of the requirements for shikimic acid and the remaining one-third is met by engineering the bacterium Escherichia coli to produce the chemical — which is not cost-effective.

The researchers screened 210 tree species in the Western Ghats region for shikimic acid content and shortlisted seven trees that contain 1–5 per cent shikimic acid by dry weight.  

The acid is mostly present in the leaves of these trees. This is an advantage, the scientists report, as the sheer volume of leaves present on trees — compared with fruits — will make extraction cheaper.

"Leaves are abundant and present throughout the year," Ramanan Uma Shaanker, a researcher at the University of Agricultural Sciences in Bangalore, and one of the authors of the paper, told SciDev.Net.

The scientists are optimistic about the extraction of shikimic acid from the trees.

"Industries have existing technologies for isolation of shikimic acid from Illicium vernum [the Chinese plant]. The same could be applied to these [Western Ghats] plants as well with minor modifications," says Uma Shaanker. The process is relatively simple as shikimic acid is highly water soluble, he says.

Besides isolation, commercialisation would require bulk extraction on a large scale and validation of the shikimic acid content.

Shaanker's laboratory now plans to demonstrate the feasibility of bulk extraction — in tens of kilograms compared to milligrams in the laboratory — in the two species, Araucaria excelsa and Calophyllum apetalum, with the highest shikimic acid content.

Link to full article in Current Science [43kb]

添加你的评论

这是您的网络:张贴您的评论,和别人分享您关于我们的任何文章的观点。

您需要注册后发表评论或者给作者发送评论的邮件。请登陆或注册。 登陆 或者 注册.

所有的评论都要接受审核,我们保留对评中包括 不适当/不适合的语言进行编辑的权利。科学与发展网络享有网站发布所有内容的版权。请查看使用条款了解详情。

只要适当标明来源与作者就可以免费复制科学与发展网络所有内容。更多详情请参见 发表评论.

返回 新闻
到达顶部